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Abstract
Background: Iranian health sector encountered many challenges in resource allocation and health service purchasing
during the past decades, the aim of this study was to determine the main challenges of the present process of health
service purchasing for national policymakers and other developing countries with the same setting.
Methods: It was a qualitative study carried out via the complete content analysis of all relevant national documents
from 2007 to 2014. In order to retrieve the related documents, we searched the official websites related to the Ministry
of Health and Medical Education, four main Iranian insurance organizations, the Health Committee of the Parliament
Profile, strategic vice president’s site and Supreme Insurance Council. After recognition of documents, their credibility
and authenticity were evaluated in terms of their publication or adjustment. For the analysis of documents, the four
step-Scott method was used applying MAXQDA version 10.
Results: Findings illustrated that health service purchase challenges in the country can be classified in 6 main themes
of policy-making, executive, intersectional, natural, legal and informational challenges with 26 subthemes. Furthermore,
5 themes of Basic Benefit Package, Reimbursement,Decision making, Technology and Contract are considered as the
main Challenges in pharmaceutical purchasing area containing 13 relevant subthemes.
Conclusions: It seems that according to documents, Iran has faced many structural and procedural problems with the
purchase of the best health interventions. So it is highly recommended to consider consequences derived from the
present challenges and try to use these evidences in their policy making process to decrease the existed problems and
move to better procurement of health interventions.
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Background
Health services purchasing is defined as a process
through which the accumulated resources are allocated
to healthcare providers by a resource allocation and pur-
chasing (RAP) agency [1]. In other words, purchase is a
procurement mechanism of healthcare services whereby
accumulated sources are paid to suppliers in order to
carry out a set of effective interventions to promote peo-
ple’s health [2].
Evidences demonstrate that the insurance companies as
RAP agencies may purchase healthcare services with two
different methods; passive purchase or strategic/active one
[3]. Passive purchase is stated to the situation that an in-
surance company has a passive status in selecting, con-
tracting and procurement of the services and its only duty
is reimbursement of the payment for healthcare services
which are prescribed for by providers [4]. In contrast, stra-
tegic purchasing defines as the constant search for
cost-effective, high quality services by an insurance com-
pany to procure the best interventions actively. Evidence
emphasizes on the vast range of strategic purchase
achievements the same as: cost saving, availability, quality
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and satisfaction of customers and technical and allocative
efficiency outcomes [5].
Evidences show that in order to implement strategic
purchasing in some developed countries, attempts are
made for separating the pooling and purchase functions
and also for allocating resources from one pooling
organization to purchases via adjusted percapita for
obtaining the purchase competition advantages [6]. On
the other hand, in these countries, there is an inclination
to use models depend on purchase. In these models,
governmental and quasi-governmental payers and third
party insurers as RAP agencies are organizationally sepa-
rated from healthcare providers [7]. This can facilitate
the potentiality of selecting more effective services and
fair-play contracting between the insurer and provider
[7]. It is obvious that in the lack of this separation, sup-
plier induced demand may be increased and the power
of bargaining, negotiation and purchasing of the insurer
will be decreased [4, 8].
Iran as a developing country in the Middle East with
about 80 million population has four main governmental
social insurance companies. The coverage of insured
people by these organizations is totally about 90%. These
organizations have similar structure in a way that the
mechanism of revenue collection in the term of pre-
mium, pooling and purchase are integrated in an
organization and resource allocation and purchasing
healthcare services are occurred passively through bud-
geting [9]. In another words, these insurers procure and
purchase healthcare interventions for their insurant
from both governmental providers affiliated with Minis-
try of Health and Medical Education and private pro-
viders with different tariffs [10]. Despite high insurance
coverage in the country, insurance organizations do not
have an essential role in the aggregation and manage-
ment of health service resources. As there is no specific
policy in the selection of interventions in resource
provision of health service, providers who influence de-
termining policies and resources, play prominent roles
in choosing interventions. Continuing this situation, may
lead to decrease in resources and lower quality services
proceured by insurers and this faulty process will lead to
the role of insurance causing a decline in the fair partici-
pation in providing financial resources for health ser-
vices [8].
Correspondingly, various studies have mentioned in-
sufficient insurance coverage, lack of competition due to
reliance of most insurance organizations on government,
low variety of benefit packages and dissatisfaction of
insurant as the most important challenges encountered
by insurance organizations in Iran [9, 10]. Rising in in-
surance organization costs, lack of appropriate referral
system, lack of service integrity in different treatment
levels, serious problems in payment system to service
providers, the purchase of similar services with different
tariffs, emphasis on the use of modern technology and
expensive ineffective drugs, lack of clarity in the rela-
tionships among producers of health services, providers,
policy makers, supervisors and service purchasers, at-
tempts of service providers to change implicit needs to
explicit demands and high out of pocket payment by the
insurant are considered as the other Iranian insurance
companies` challenges [2].
As it is obvious although these studies point to some
challenges applying experts opinions, their results need
to become more complete and applicable by an exact at-
tention to existing policies, regulations and programs
and the contrasts between these documents and the ex-
perts points of view. For instance, high-level legal re-
quirements of the country including the fifth
social-economical development laws requires the health
insurance to purchase strategically health services from
governmental and non-governmental sections consider-
ing referral system and ranking national services and ap-
proved policies and priorities of health system with the
aim to achieve its pervasive and fair coverage, to in-
crease the availability of health services and to purchase
the highest quality and most effective services [11].
According to what was said, the present study deals
with the complete analysis of all relevant national re-
sources to determine challenges of the present process
of health service purchasing for national policymakers
and those with the similar problems like Iran. The con-
tribution to knowledge for the present study is to
complete the previous studies by determining the main
challenges in purchasing health care services and phar-
maceuticals in Iranian health sector from the perspective
of national documents, laws and legislations other than
experts opinions that was considered before.
Methods
Design
The current study is a qualitative one which is carried
out via the qualitative narrative document analysis.
There are various methods for collecting qualitative data.
Gupta believes that in performing qualitative studies,
one can use some of the previous data such as docu-
ments or other textual data. By existing textual data and
documents in this type of research, instructions and gov-
ernmental circulars such as official documents, pro-
grams and issued policies and periodic reports are
meant [12]. At the same time Krippendrof believes that
documents or other text data like government guidelines
and directives, official documents, programs and policies
and periodic reports can be analyzed in a hermeneutic
approach through a five-step process containing access
to documents and data, checking the validity of docu-
ments, comprehending the documents, analyzing the
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data and applying the information in the form of ex-
tracted themes [13]. In this approach, the qualitative re-
searcher aims to seek those themes existing in one
document or the groups of documents that requires an
exact investigation of the documents in order to com-
prehend the viewpoints of the writers or experts who
prepared those texts [14].
As the national documents, laws and legislations can be
considered as the main policy-making guidelines, and
their contents can clarify the main viewpoints and strat-
egies of that country in each scope, in order to answer the
present research question to achieve the main challenges
in purchasing health care services and pharmaceuticals in
Iranian health sector, the qualitative document analysis
was applied as the study methodology.
Data collection
In this regard, as we thought that formal laws and legisla-
tions accompanied with other formal documents and re-
ports existing in health care sector may lead us to many
present challenges in health care purchasing, we decided to
retrieve the related documents systematically, we searched
the official websites related to the Ministry of Health and
Medical Education [http://www.behdasht.gov.ir/], Social Se-
curity Organization [http://www.msio.org.ir], Iran Health
Insurance Organization [http://tamin.ir], Imam Khomeini
Relief Committee [http://ihio.gov.ir/], Armed Forces Health
Care Insurance[http://mod.ir/], as four main insurance
organization in Iran, the Health Committee of the Parlia-
ment Profile [http://rc.majlis.ir/fa/parliament_commission/
health], strategic vice president’s site (the Management and
Planning Organization) [https://www.mporg.ir] and Su-
preme Insurance Council [http://centinsur.ir/].
In order to create a logical trend and to prevent the
loss of relevant data, the document collection and ana-
lysis form was used. This form was prepared by the re-
search team for the initial investigation of existing
documents and records. The items including this form
were the name of the document, the place of retrieving
the document and related clarifications about the con-
tent of the document in the above scopes. The content
validity of the data collection form was confirmed by the
research team.
In order to collect data, first we tried to search the
above websites electronically applying related keywords
and phrases regarding “financial provision methods of
health services”, “health insurance”, “the purchase of
health services” and “the present situation of purchasing
health services” and “pharmaceutical purchasing” from
2007 to 2014. As we thought some documents could not
be retrieved electronically, one of the researchers referred
to library resources and centers of the Ministry of Health
and Medical Education, Food and Drug Organization, the
Research Center of the Parliament and basic insurance
companies of the country. This set of documents were
chosen because the stated organizations and their related
documents, laws and legislations contain all the Iranian
legal considerations in health sector and purchasing health
care services as well and they can be used as a compre-
hensive source of documents leading us to answer the re-
search question.
Validation method
A 4- step Scott method was used for data collection in
order to determine authenticity, credibility, representa-
tiveness and meaningfulness of data [15]; in the first step
in order to assure authenticity, the offering source of
documents was investigated in a way that in this stage
those documents which were verified by the Parliament,
government, Supreme Insurance Council and insurance
organizations were regarded authentic.In the second step
as a process of determining credibility, only those docu-
ments were verified which were not misleading and were
free of mistakes and in general did not have any personal
and organizational conflict of interest. Representative-
ness in the third stage meant that the investigated docu-
ments showed general policies or determined keywords
on the basis of purpose of research and finally at the last
step, meaningfulness meant that the document was clear
and comprehensive and in a way had face and content
validity. In other words, both its appearance and format
should have credibility. Identified documents, after
quadruple stages according to Scott criterion were sub-
jected to content analysis in the next stage word by word
explicitly and implicitly in an inductive and deductive
way [16]and those documents which do not have even
one of the quadruple indexes including by Scott were
excluded from content analysis. In this regard a total of
29 documents out of 41 included in the study in nine
main categories consisting national plans, laws, regula-
tions, policies and legislations (Table 1). Finally, these in-
cluded documents contain general present challenges of
Iranian context and the proposed policies, laws and reg-
ulations for improving the situation as well (Fig. 1).
Data analysis
Content analysis dealt with both deductive and inductive
approaches for data analysis. The description of analysis
was as follows:
In the first phase, we chose a deductive approach to
verify the main categories of purchasing challenges in
health system. The predetermined codes for categorising
the challenges were extracted through the literature re-
view. These codes contain pharmaceutical purchasing
challenges and health care purchasing challenges. In this
regard, explicit analysis was applied. We looked for the
exact words or phrases containing all of the followings:
“challenges OR problems OR difficulties”, “purchase OR
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purchasing OR procure OR procurement”, “health OR
health system”. After finding the exact keywords, we
highlifht them in the whole body and only went through
the frequency and repetition of the words [17]. By con-
sidering the more repeated words, we confirmed the
main deterrmined codes in this phase.
In the secend phase, the related items were attributed
to one of the main categories using inductive approach
applying a 5-step framework. For the inductive analysis,
first the authors read all the texts for several times to
familiarize with the content, then at the next step, we
tried to develop a framework assisting the pre deter-
mined key words and expressions and during this step
all the texts were reviewed again in order to highlight
the meaningful units of the text with an implicit ap-
proach, at the same time in this step we tried to agree
on the meaning definition of “challenge” in health care
purchacing and pharmaceuticals as well. In this regard,
we searched the concepts and similar topics such as
comprehensive health coverage, Health insurance, health
services purchase, financial provision of health, etc. in
the documents` content, then at the third step, we
started to initial indexing and creating codes in a way
that after finding each of the above phrases or words
based on the researchers critical assessment and their
privious knowledge as an expert in this scope (P.B wrote
a dissertation in healthcare and pharmaceutical purchas-
ing and R.D is a policy maker in healthcare scope), we
highlighted them in the body and then devoted an ap-
propriate code for each determined pharase. These
codes were reviewed for many times to develop new
codes and be assured of merging the repeated ones,
MAXQDA version 10 was used in this step. Then at the
fourth stage charting was occurred and we tried to
merge the related codes to generate sub categories as
sub themes and then achieved to main categories or
themes. In this step the relation between the main and
subthemes were identified too and at the last step, all
the themes and subthemes were interpreted and ap-
proved by the research team that did not have any con-
flict of interest [18].
About the ethical consideration of the study it is im-
portant to consider that all the documents and their
content were analyzed in the way that there was no
name of any of Iranian politicians, policy makers or ex-
ecutive managers, and only their content was used for a
qualitative analysis without any conflict of interest by
the research team.
Results
The findings of the obtained document analysis indi-
cated that in the insurance system of Iran the purchase
of health services is done passively. In other words, sum-
ming up obtained data driven from present condition of
the purchase of health services demonstrated the fact
that what has been done by insurance organizations re-
garding the identification of the best providers/suppliers
of services follows traditional supervision programs
without any potentiality for ranking the best suppliers by
the insurance organization and also no power for the
organization to bargain, negotiate and contract with the
best selected supplier and at present, it seems from evi-
dences that a comprehensive program for ranking
healthcare providers has been missing yet. Furthermore,
there is no possibility of the complete identification of
current novel medical services, the purchase of best ser-
vices is not carried out. In addition, the most widespread
method which is a criterion in insurance organizations
payment system, is that of payment in return for service
reception. Finally, only the villagers and nomads insur-
ance fund (it is a part of Iran Health Insurance
Organization) use a mass purchase mechanism for pro-
curement of services and the other insurance
organization just reimburse the payments related to the
prescriptions that occurred retrospectively.
However, obtained data from insurance organizations
denote their contract formation with more than 45,000
providers of diagnostic and curative services in 2013.
These providers spread out all over the country and
Ministry of Health and Medical education suffers an
Table 1 Final categories of studied documents
No Final categories of studied documents Number of
documents
1 Fourth social economic development plan 1
2 Fifth social economic development plan 1
3 Health care purchasing executive regulation 4
4 Documents of superior council of insurance 7
5 Regulations according to basic benefit package 4
6 Regulations according to pharmaceutical
inclusion criteria and pharmacopeias
4
7 Regulations about health technology
assessment
3
8 Regulations about health tariffs 2
9 Laws and regulations related with
supplementary insurers
3
Fig. 1 The chart of document acquisition
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inefficient system for their evaluation and supervision
because of the lack of applied policies, inappropriate
mechanism for monitoring them and concentrating the
duties of policy making, implementing and evaluating in
the same units.
Other obtained data which are taken from investigated
document analysis illustrated that health service pur-
chase challenges in the country can be classified in six
main themes of policy-making, executive, intersectional,
natural, legal and informational challenges. In this regard
Table 2 depicts the most significant themes (6) and
sub-themes (26) which are gained from present docu-
ment analysis.
Though the aforementioned challenges are generally of-
fered by insurance organizations in the country for the
purchase of all health services, the coverage of these draw-
backs in pharmaceutical section is evidently one of the
most important health services. To put it another way, all
the six mentioned challenges can be verified in the theme
of purchase and preparation of pharmaceuticals. More-
over, other problems other than the above challenges were
identified by insurance organizations which are put in the
forms of five themes and thirteen sub-themes in Table 3.
As it is depicted in Table 3, insurance organizations do
not follow the same pharmacopeia for the purchase of
medicines. In other words, each insurance organization
has a different basic drug list. However, most people
who are insured by basic insurance funds especially the
Health Insurance fund have scant availability to needed
drug and does not suffice the pharmaceutical require-
ments of the poor and vulnerable people.
On the other hand, other basic insurance organiza-
tions of the country do not pay sufficient attention to
moral hazard and adverse selection leads to the expend-
iture of a bulk of medicinal credit resources for only a
few limited people who unfairly cause the highest medi-
cinal costs. In addition, at the time of allocation of re-
sources to different drug categories and drug items
cost-effectiveness and economical evaluation are not
much considered in decision-making.
The inappropriate and long reimbursement procedure
of drug costs to patients by insurance organization _only
after paying out of pocket for a large spectrum of expen-
sive drug by patients having refractory diseases _ is an
important challenge which is put in Table 3. This im-
proper drug reimbursement together with different pay-
ment levels and limits among insurance organizations
for the same services is another challenge of this theme.
Exerting pressure by providers of services and phar-
maceuticals is another principal challenge of this
theme, in another words, because of the lack of ac-
cepted official guidelines, providers like physicians have
the power to prescribe those pharmaceuticals and ser-
vices that they prefer.
Table 2 Health Care Services Purchasing challenges of Iranian
Insurance Companies
Themes Sub Themes
Policy making Challenges External and political forces on insurers for
contracting with providers
ambiguities in strategic purchase policies
lack of regulations, evaluation instructions
and ranking providers of services
Lack of purposefulness of subsidies for
purchasing agencies
lower per capita income in those under
medical services coverage
High rate of out of pocket because of low
coverage of services
great number of households facing
catastrophic costs especially in outpatient
services
Executive Challenges lack of effective referral system based on
family physician in the whole country
different prices for the same service by
insurance organizations
heterogeneous distribution of medical
experts in different parts of the country
lack of realization of universal health
coverage
lack of exclusive use of power of purchase
(use of inactive purchase).
Intersectional Challenges Low level of relations between insurance
organizations and scientific& expert
associations
lack of competition among insurance
organizations
lack of clarity in the relationships among
producers of health services, providers,
policy-makers, supervisor and purchaser
of services in the country
the existence of supplementary insurances
which buy basic services several times that
of the original price
Natural Challenges The existence of high induced demand in
outpatient and drug sections
Existence of spiral of death because of
adverse selection outbreak
Radar syndrome because of the lack of
continuity in offering services level
Cream scheming in some insurance
companies
Legal Challenges Lack of an exact and scientific basis in
assessing insurance rights and tariffs
The high range of inpatient in patient
costs
Persist on implementing the governmental
model of family physician and referral system
lack of regulations and instructions of health
care delivery
Informational Challenges lack of a comprehensive information bank
lack of sufficient familiarity with successful
health systems experiences in strategic
purchase of health services
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because of the brand loyalty or sometimes their personal
benefits but without any confirmed cost-effectiveness in-
dexes or approved evidences. Moreover, a great amount of
costs of basic insurance organizations is spent on pharma-
ceuticals and medical equipment. It can be a problem when
we consider that a great portion of this amount is allocated
to antimicrobial medicines. Some of them are prescribed
with no indications the same as those are used as prophy-
laxis and those prescribed irrationally. Biopharmaceuticals
and OTCs that are usually considered as brand medicines
are the other costing center in this area. In this regard, ac-
cording to existing evidences, the highest rank is related to
Oil Company as one of the minor insurance companies in
the country and Social Security Organization and the low-
est is pertinent to supplementary insurances. Supplemen-
tary insurances are created because of the weak coverage of
the basic packages of the social insurance companies in the
country. They are considered as private purchasers with
higher premium and only rich people with the higher po-
tentiality of payment can use their coverage especially for
expensive treatments and medicines.
Finally, lack of ranking of pharmaceutical supplies by
supervisional institutions such as Ministry of Health and
Medical Education is among other challenges which
cause some problems in forming appropriate contracts
which are agreed on and the purchase and preparation
of most effective drug for insurance organizations. This
challenge causes that a purchaser could not have the
power of negotiation, bargaining and contracting with
the best approved supplier of pharmaceuticals.
Discussion
Implementing healthcare strategic purchasing especially
for developing countries is emphasized by World Health
Organization and the World Bank [19]. The present
findings indicate some challenges in the way of achieving
strategic purchasing in Iranian health sector as:
Policy-making, executive, intersectional, natural, legal
and informational challenges.
In policy-making, the current findings emphasize the am-
biguities in strategic purchase policies and lack of regula-
tions, evaluation instructions and ranking suppliers and
providers. In this respect, Moghaddasi et al. considered the
lack of clarity of insurance policies in procuring medical
service as the most significant obstacle for optimal pur-
chase of health services [16]. Maleki et al. also regards
policy-making in determining insurance rights as one of
the chief drawbacks in Iran insurance organizations [20].
Lack of purposefulness of subsidies for purchasing agencies
are among other present policy making challenges. Like-
wise, Maleki referred to lack of purposefulness of subsidies
[21]. It seems that giving subsidies to purchasing institution
can lead to strategic purchasing and also maximizing the
access and equity than offering subsidies to providers or pa-
tients. Some more challenges in policy-making consider
those under medical services coverage have low per capita
income in comparison with others. These people face more
out of pocket payment because of low coverage of services
and great number of households facing catastrophic costs
especially in outpatient services. In this regard, lack of a
system for putting tariffs, unreal per capita income in the
country, unfair and retrogressive financial provision system
are among the challenges mentioned by Dehnaviehet al
[22]. VafaeeNajjar et al. has referred to mere coverage of ex-
pensive admission and recognition services with a specific
limit for cost payment by these organizations [23]. This can
justify the current findings on catastrophic costs in out-
patient section.
The most executive challenges are indicated as: lack of ef-
fective referral system based on family physician, different
prices for the same service by insurance organizations, het-
erogeneous distribution of medical experts in different parts
of the country, lack of universal health coverage and lack of
exclusive use of power of purchase. In this regard, Hassan-
zadeh, has mentioned that the demand of the patients and
induced demand toward suppliers are determinant factors
for purchasing services instead of the community real
needs and evidence-based guidelines [2]. Moreover, lack of
appropriate referral mechanism is another challenges in
Table 3 Pharmaceutical Purchasing challenges of Iranian
Insurance Companies
Themes Sub Themes
Basic Benefit Package
Challenges
Narrow pharmaceutical packages
Different pharmaceutical packages among
various insurers
Reimbursement
Challenges
Incorrect cycle of funds in pharmaceutical
section by theinsurers
Incorrect and long process of
pharmaceuticalreimbursement
Difference in payment ceilings for the same
pharmaceuticals
Difference in payment levels and payment
mechanisms of pharmaceutical by
various insurers
Decision making
Challenges
Existence of adverse selection and moral
hazard in pharmaceutical sector
Lack of attention to cost effectiveness
implications in pharmaceutical purchasing
Technology Challenges Force on applying new technologies and
expensive pharmaceuticals
Devoting great costs to pharmaceutical
sector and high technologies
Contract Challenges Lack of existence fair contracts for
pharmaceutical purchasing
Lack of purchasing grand use pharmaceuticals
through mass purchase
Lack of ranking the pharmaceutical providers
by policy makers
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insurance system in the country [2]. Although from the
year 2005 the rural family physician proposal for all villages
and from 2011 the urban family physician plan were piloted
for two provinces as a referral system, evidences show that
not much success has been achieved in solving executive
problems of insurance organizations [11]. So, it seems that
if Islamic republic of Iran plans to reach the goal of univer-
sal health coverage as a serious executive solution, it needs
a systematic approach which is based on planning. In a cor-
responding way, Young et al. have considered essential the
four stages of determining interventions, selecting interven-
tions, evaluating technology and evaluating interventions as
an optimal strategy for determining interventions which are
to be placed in the service package and access to a universal
health-coverage [24].
Intersectional challenges are devided to low level of rela-
tions between insurance organizations and scientific associ-
ations, lack of competition among insurance organizations,
lack of clarity in the relationships among producers of
health services, providers, policy-makers, supervisor and
purchaser in the country and the existence of expensive
supplementary insurances. Correspondingly, Hassanzadeh
pointed to the lack of clarity in the relationships among
producers, providers, policy-makers, supervisors and
purchasers of services [2] which similar to the findings
of the current study underlines the necessity of inter-
sectional and intra-sectional interactions and creation
of a correct supervision mechanism and exact defin-
ition of policy-making cycle.
The most important natural challenges include the ex-
istence of high induced demand in outpatient and drug
sections, adverse selection, radar syndrome (lack of fol-
lowing people by a referral system and just providing
services at the time of illness), lack of continuity in offer-
ing services and cream scheming in funds. In this re-
spect, Dehnavieh has referred to the high levels of
induced demand [18]and Hassanzadeh has mentioned
the openness of medical services` supply through an in-
crease in the number of providers due to the training of
extra labor force and the occurrence of induced demand
and increased expenses in insurance organizations and
out of pocket payment [2].
Among legal challenges, the present findings declare
the lack of an exact and scientific basis in assessing pre-
miums and tariffs. In this regard, lack of scientific pre-
miums, the retrogressive state of premiums, unreal
tariffs and under the table health fees were the most im-
portant drawbacks identified by Maleki et al. [21]
Finally, the current informational challenges were the
lack of a comprehensive information bank and lack of
sufficient familiarity with successful health systems expe-
riences in strategic purchase of health services. It seems
that an emphasis on compilation and application of
standard instructions, distribution of evaluation system
of technology and creation of a comprehensive informa-
tion system can help solving these challenges.
Regarding pharmaceutical purchase challenges the
present findings particularly demonstrate the challenges
related to purchase basic benefit package, reimburse-
ment, decision-making, technology and contract.
An important challenge is that pharmaceutical packages
do not have enough coverage and there are different phar-
macopeias approved by different insurance funds. In this
respect, offering national drug pharmacopeia seems essen-
tial. Highlighting cost-effectiveness requirements are
among other aspects which should be considered as an
important factor while purchasing and as an important
criterion while compiling, changing and amending service
package by insurance organizations though the present
findings mention it as a decision-making challenge. Cor-
respondingly, Brenfort et al. indicated that for including
pharmaceuticals to Sweden basic service package, need
criterion was only taken into consideration and
cost-effectiveness criterion was rarely regarded [25]. How-
ever, Makundi et al. emphasized the revision of evidences
related to selected cost-effectiveness of interventions
through systematic search of Medline and Cockrane on
cost-effectiveness of interventions [26].
Other findings lay emphasis on putting pressure for
the use of modern technology and expensive drug. In
this regard, Hassanzadeh has acknowledged that a push
for the use of modern technology and expensive, inef-
fective drug along with uplifting expectations of the soci-
ety using unusual comparisons can impose a lot of
trouble on insurance organizations [2].
The lack of possibility to make a win-win contract be-
tween purchasing organizations and drug suppliers and
the lack of possibility to choose the best supplier from in-
surance organization due to lack of ranking by the Minis-
try of Health and Food and Drug Organization are among
other challenges in the present study which can pose great
problems in putting strategic purchase into practice, in
this regard, Arney et al. claimed that applying the strategic
plan for contracting can provide the opportunity for sus-
tainable improvements inprocurement efficiency and
commodity availability [27]at the same time other evi-
dences showed that using strategic purchasing in pharma-
ceutical sector can not achieved without improving the
ability of contracting between purchasers and suppliers
[16].Bastani et al., also emphasized that pharmaceuticals
price, real and fair premiums along with the ability of fair
contracting with the main suppliers and correcting reim-
bursement mechanisms toward purchasers are considered
as contracting and purchasing incentives [28].
From the main limitations of the study we can point
to the lack of complete access to all libraries specially
those related to Armed Forces Health Care because of
their confidentiality, another limitation can be the study
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perspective that focused on formal documents, laws and
legislations.
Conclusion
With respect to what has been stated, it seems that ac-
cording to documents, Iran has faced many structural
and procedural problems in the purchase of the best
health interventions, particularly in the purchase of
drug. It is crystal clear that only by highlighting present
laws and regulations and offering strategies for applying
them along with designing appropriate organization
structure, reducing concentration in decision-making,
creating information integration, intensifying competi-
tion in health services purchase market and establishing
optimal system for the evaluation of both institutions of-
fering services and purchasers, the country can reduce
the present challenges and move towards strategic pur-
chase as a strategy for increasing justice and efficiency.
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